Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Tykerb
Asia
Big Pharma offers blockbuster discounts to win China coverage
After an average 44% price cuts, Chinese government will add some blockbuster foreign meds like Celgene's Revlimid to its national insurance scheme.
Angus Liu
Jul 19, 2017 10:47am
FiercePharmaAsia: PRA and Takeda’s Japan JV, Sun, ASLAN and more
Feb 17, 2017 9:31am
ASLAN posts positive top-line varlitinib phase 2 data in breast cancer
Feb 16, 2017 10:30am
CEO says Puma sorted neratinib's diarrhea problem as analysis cites risks
Sep 27, 2016 10:07am
